Aclaris Therapeutics, Inc. (NASDAQ:ACRS) announced positive data from the phase I ATI-450-PKPD-101 study on it investigational MK2 inhibitor, ATI-450, currently being developed...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has rendered a positive...
Shares of General Motors Company (NYSE:GM) gained 1.1% after the company reached a deal with the United Auto Workers union to end a month long strike at General Motors.Shares of...
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) announced that it has sold worldwide rights to its rosacea drug, Rhofade Cream, and certain licenses to related intellectual property...
As of late, it has definitely been a great time to be an investor in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) . The stock has moved higher by 30.9% in the past month, while it is...
Pacira BioSciences, Inc. (NASDAQ:PCRX) delivered second-quarter 2019 earnings of 41 cents per share, surpassing the Zacks Consensus Estimate of 34 cents and also the year-ago...
Zoetis Inc. (NYSE:ZTS) posted second-quarter 2019 adjusted earnings of 90 cents per share (excluding one-time items), which not only increased 16.9% year over year from 77 cents...
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) has enrolled the first patient in a pivotal phase III study evaluating Tavalisse (fostamatinib disodium hexahydrate) as a treatment for...
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical...
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) , a dermatologist-led specialty pharmaceutical company, could be an interesting play for investors. That is because, not only does the...
Textbook pump and dump. "Pump and dump" (P&D) is a form of securities fraud that involves artificially inflating the price of an owned stock through false and misleading positive statements, in order to sell the cheaply purchased stock at a higher price. Once the operators of the scheme "dump" (sell) their overvalued shares, the price falls and investors lose their money.
1
based on the very wealthy berg that I know pushing this...it's absolutely a pump and dump.
0
was up by 200%. What do you think now ?
It's still holding $17 is a surprise.
Not gonna hold here for long.
1
Why? Do you know anything about this company? The comments on this investing app are always remedial. Come to this app if you want CNN BS
0
17 tomorrow
0
should i buy this stock right know ???
3
should i buy this stock right know ???
3
why that much up????
0
Do your homework. Like a good citizen who pays back to his country daily, instead of expecting from it, be proactive, learn, research, be aware and educated - so when you come to invest, you make better decisions and not like those lousy losers who stormed the capitol - don't be a loser!
Paul Bert i would not touch it now, it is all spec right now
0
i have 400 of them on $16.20, already make $4000
0
Paul Berti didnt read the news and i thought it was one of those pump and dump, then i got all rock headed and got myself burned, i pulled out on 16 so im not at a total loss.